Skip to main content
. Author manuscript; available in PMC: 2016 Apr 13.
Published in final edited form as: Vaccine. 2015 Jan 15;33(9):1168–1175. doi: 10.1016/j.vaccine.2015.01.004

Table 2.

Evaluation of implementation of AMES–AESb surveillance targeting Japanese encephalitis and bacterial meningitis in Bangladesh (BNG), China (CHN) and India (IND), using four qualitative indicators.

Indicator Component JE surveillance
Bacterial meningitis surveillancea
Max scoreb BNG CHN IND Max score BNG CHN
1. Training Content based on technical protocol   1   1   1   1   1   1   1
Target audience relevantc   1   1   1   1   1   1   1
Timing appropriated   1   1   1   1   1   1   1
Total   3   3   3   3   3   3   3
2. Availability of laboratory resources Appropriate equipment in placee   2   2   2   2   2   1   1
Appropriate reagents in placee   2   1   2   1   2   1   1
Total   4   3   4   3   4   2   2
3. Data standardization Electronic data managementf   2   1   1   2   2   1   1
Surveillance, laboratory data linkableg   2   2   2   1   2   2   2
Total   4   3   3   3   4   3   3
4. Effectiveness of building on polio–measles (PM) networks Surveillance protocols, tools adaptedh   2   1   1   1   2   1   1
PM district staff oversaw sentinel sites   2   2   2   2   2   2   2
PM national staff oversee surveillance   2   2   2   1   2   2   2
PM regional bulletins adapted   1   1   0   1   1   0   0
Laboratory protocols, tools adaptedi   2   2   2   2   2   0   0
PM laboratory staff utilized   2   2   2   1   2   0   0
PM regional staff oversaw laboratory   2   2   2   2   2   0   0
Total 13 12 11 10 13   5   5
Total 24 21 21 19 24 13 13

AMES–AES, acute meningitis-encephalitis syndrome/acute encephalitis syndrome.

a

India did not conduct surveillance for bacterial meningitis.

b

Components that could be answered in a “yes/no” fashion, were each worth 1 point (e.g., all components for training and one component of effectiveness of building on polio–measles networks); components that could be measured for each year of surveillance, were each worth 2 points (e.g., components for availability of laboratory resources, data standardization and other components for effectiveness of building on polio–measles networks).

c

Surveillance, laboratory and clinical staff at all levels.

d

Introductory training prior to launch and refresher training as needed.

e

For encephalitis surveillance, equipment and reagents to perform JE IgM ELISA at all laboratories; for meningitis surveillance, equipment and reagents to perform Gram stain and bacterial culture at sentinel site laboratories, and to perform real-time PCR at secondary laboratories in all three countries and tertiary laboratories in China.

f

Electronic data base used for local database for surveillance (1 point) and laboratory (1 point) data.

g

National level surveillance data easily linked with laboratory data.

h

Protocols and tools for case investigation, line listing, reporting, monitoring, data management and feedback.

i

Protocols and tools for specimen transport, laboratory reporting, monitoring and data management.